Literature DB >> 21284051

Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging.

S Keereweer1, H J C M Sterenborg, J D F Kerrebijn, P B A A Van Driel, R J Baatenburg de Jong, C W G M Löwik.   

Abstract

A key aspect for the postoperative prognosis of patients with head and neck cancer is complete tumor resection. In current practice, the intraoperative assessment of the tumor-free margin is dependent on visual appearance and palpation of the tumor. Optical imaging has the potential of traversing the gap between radiology and surgery by providing real-time visualization of the tumor, thereby allowing for image-guided surgery. The use of the near-infrared light spectrum offers 2 essential advantages: increased tissue penetration of light and an increased signal-to-background ratio of contrast agents. In this review, the current practice and limitations of image-guided surgery by optical imaging using intrinsic fluorescence or contrast agents are described. Furthermore, we provide an overview of the various molecular contrast agents targeting specific hallmarks of cancer that have been used in other fields of oncologic surgery, and we describe perspectives on its future use in head and neck cancer surgery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284051     DOI: 10.1002/hed.21625

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  29 in total

1.  Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.

Authors:  C Hope Heath; Nicholas L Deep; Larissa Sweeny; Kurt R Zinn; Eben L Rosenthal
Journal:  Ann Surg Oncol       Date:  2012-06-06       Impact factor: 5.344

2.  Design and characterization of an optimized simultaneous color and near-infrared fluorescence rigid endoscopic imaging system.

Authors:  Vivek Venugopal; Minho Park; Yoshitomo Ashitate; Florin Neacsu; Frank Kettenring; John V Frangioni; Sidhu P Gangadharan; Sylvain Gioux
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

3.  Force adaptive robotically assisted endomicroscopy for intraoperative tumour identification.

Authors:  Petros Giataganas; Michael Hughes; Guang-Zhong Yang
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-23       Impact factor: 2.924

4.  Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.

Authors:  Tiara S Napier; Neha Udayakumar; Aditi H Jani; Yolanda E Hartman; Hailey A Houson; Lindsay Moore; Hope M Amm; Nynke S van den Berg; Anna G Sorace; Jason M Warram
Journal:  Mol Cancer Ther       Date:  2020-06-30       Impact factor: 6.261

Review 5.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

6.  A high-affinity near-infrared fluorescent probe to target bombesin receptors.

Authors:  Ajay Shrivastava; Haiming Ding; Shankaran Kothandaraman; Shu-Huei Wang; Li Gong; Michelle Williams; Keisha Milum; Song Zhang; Michael F Tweedle
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

7.  NIR-emissive PEG-b-TCL micelles for breast tumor imaging and minimally invasive pharmacokinetic analysis.

Authors:  Christina L Hofmann; Melanie C O'Sullivan; Alexandre Detappe; Yingjie Yu; Xi Yang; Wei Qi; Chelsea D Landon; Michael J Therien; Mark W Dewhirst; P Peter Ghoroghchian; Gregory M Palmer
Journal:  Nanoscale       Date:  2017-09-21       Impact factor: 7.790

Review 8.  EGF receptor-targeted nanocarriers for enhanced cancer treatment.

Authors:  Alyssa M Master; Anirban Sen Gupta
Journal:  Nanomedicine (Lond)       Date:  2012-12       Impact factor: 5.307

9.  Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.

Authors:  C Hope Heath; Nicholas L Deep; Lauren N Beck; Kristine E Day; Larissa Sweeny; Kurt R Zinn; Conway C Huang; Eben L Rosenthal
Journal:  Otolaryngol Head Neck Surg       Date:  2013-03-22       Impact factor: 3.497

Review 10.  Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges.

Authors:  Michelle D Williams
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.